Vistagen Therapeutics (VTGN) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for Vistagen Therapeutics (VTGN) over the last 10 years, with Q4 2025 value amounting to -$939000.0.
- Vistagen Therapeutics' Other Gross PP&E Adjustments rose 3572.9% to -$939000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$939000.0, marking a year-over-year increase of 3572.9%. This contributed to the annual value of -$2.5 million for FY2025, which is 1930.16% up from last year.
- Per Vistagen Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$939000.0 for Q4 2025, which was up 3572.9% from -$1.1 million recorded in Q3 2025.
- Over the past 5 years, Vistagen Therapeutics' Other Gross PP&E Adjustments peaked at -$473100.0 during Q4 2022, and registered a low of -$5.2 million during Q1 2021.
- Its 5-year average for Other Gross PP&E Adjustments is -$1.9 million, with a median of -$1.5 million in 2024.
- As far as peak fluctuations go, Vistagen Therapeutics' Other Gross PP&E Adjustments surged by 6016.13% in 2022, and later tumbled by 30870.85% in 2023.
- Vistagen Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$1.2 million in 2021, then surged by 58.98% to -$473100.0 in 2022, then plummeted by 308.71% to -$1.9 million in 2023, then grew by 24.44% to -$1.5 million in 2024, then soared by 35.73% to -$939000.0 in 2025.
- Its last three reported values are -$939000.0 in Q4 2025, -$1.1 million for Q3 2025, and -$1.2 million during Q2 2025.